Inspire Medical Systems Inc (INSP)
187.83  -2.17 (-1.14%)

Inspire Medical Systems is a medical device company focused on developing innovative solutions to treat obstructive sleep apnea. The company specializes in the design and manufacturing of implantable neurostimulation devices that work to improve airflow during sleep by stimulating the hypoglossal nerve, which helps keep the airway open. Their technology aims to provide an effective alternative for individuals who are unable to tolerate traditional continuous positive airway pressure (CPAP) therapy. Through its pioneering approach, Inspire Medical Systems is committed to enhancing the quality of life for patients with sleep-disordered breathing conditions.

SummaryNewsPress ReleasesChartHistorical
INSPIRE MEDICAL ALERT: Bragar Eagel & Squire, P.C. is Investigating Inspire Medical Systems, Inc. on Behalf of Long-Term Stockholders and Encourages Investors to Contact the Firm
NEW YORK, July 17, 2024 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, is investigating potential claims against Inspire Medical Systems, Inc. (NYSE: INSP) on behalf of long-term stockholders following a class action complaint that was filed against Inspire Medical on December 22, 2023 with a Class Period from May 3, 2023 to November 7, 2023. Our investigation concerns whether the board of directors of Inspire Medical have breached their fiduciary duties to the company.
By Bragar Eagel & Squire · Via GlobeNewswire · July 17, 2024
Eli Lilly Stock Up: GLP-1 Zepbound Targets Sleep Apnea Market
Global pharmaceutical giant Eli Lilly & Co. (NYSE: LLY) has made headlines with its leading GLP-1 weight loss drugs, Mounjaro and Zepbound.
Via MarketBeat · July 1, 2024
INSPIRE MEDICAL ALERT: Bragar Eagel & Squire, P.C. is Investigating Inspire Medical Systems, Inc. on Behalf of Long-Term Stockholders and Encourages Investors to Contact the Firm
NEW YORK, Feb. 21, 2024 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, is investigating potential claims against Inspire Medical Systems, Inc. (NYSE: INSP) on behalf of long-term stockholders following a class action complaint that was filed against Inspire Medical on December 22, 2023 with a Class Period from May 3, 2023 to November 7, 2023. Our investigation concerns whether the board of directors of Inspire Medical have breached their fiduciary duties to the company.
By Bragar Eagel & Squire · Via GlobeNewswire · February 21, 2024
INSP DEADLINE TODAY: ROSEN, TOP RANKED GLOBAL COUNSEL, Encourages Inspire Medical Systems, Inc. Investors with Losses to Secure Counsel Before Important February 20 Deadline in Securities Class Action - INSP
WHY: NEW YORK, NY - (NewMediaWire) - February 20, 2024 - Rosen Law Firm, a global investor rights law firm, reminds purchasers of common stock of Inspire Medical Systems, Inc. (NYSE: INSP) between May 3, 2023 and November 7, 2023, both dates inclusive (the “Class Period”), of the important February 20, 2024 lead plaintiff deadline.
Via NewMediaWire · February 20, 2024
INSP DEADLINE TODAY: ROSEN, TOP RANKED GLOBAL COUNSEL, Encourages Inspire Medical Systems, Inc. Investors with Losses to Secure Counsel Before Important February 20 Deadline in Securities Class Action - INSP
WHY: NEW YORK, NY - (NewMediaWire) - February 20, 2024 - Rosen Law Firm, a global investor rights law firm, reminds purchasers of common stock of Inspire Medical Systems, Inc. (NYSE: INSP) between May 3, 2023 and November 7, 2023, both dates inclusive (the “Class Period”), of the important February 20, 2024 lead plaintiff deadline.
Via TheNewswire.com · February 20, 2024
INSPIRE MEDICAL 96 HOUR DEADLINE ALERT: Former Louisiana Attorney General and Kahn Swick & Foti, LLC Remind Investors With Losses in Excess of $100,000 of Deadline in Class Action Lawsuit Against Inspire Medical Systems, Inc. - INSP
Kahn Swick & Foti, LLC ("KSF") and KSF partner, the former Attorney General of Louisiana, Charles C. Foti, Jr., remind investors that they have until February 20, 2024 to file lead plaintiff applications in a securities class action lawsuit against Inspire Medical Systems, Inc. (NYSE: INSP), if they purchased the Company’s shares between May 3, 2023 and November 7, 2023, inclusive (the “Class Period”). This action is pending in the United States District Court for the District of Minnesota.
By Kahn Swick & Foti, LLC · Via Business Wire · February 16, 2024
The Law Offices of Frank R. Cruz Reminds Investors of Looming Deadline in the Class Action Lawsuit Against Inspire Medical Systems, Inc. (INSP)
The Law Offices of Frank R. Cruz reminds investors of the upcoming February 20, 2024 deadline to file a lead plaintiff motion in the class action filed on behalf of investors who acquired Inspire Medical Systems, Inc. (“Inspire Medical” or the “Company”) (NYSE: INSP) common stock between May 3, 2023 and November 7, 2023, inclusive (the “Class Period”).
By The Law Offices of Frank R. Cruz · Via Business Wire · February 16, 2024
INSPIRE MEDICAL INVESTOR DEADLINE APPROACHING: Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $100,000 In Inspire Medical To Contact Him Directly To Discuss Their Options
If you suffered losses exceeding $100,000 investing in Inspire Medical stock or options between May 3, 2023 and November 7, 2023 and would like to discuss your legal rights, call Faruqi & Faruqi partner Josh Wilson directly at 877-247-4292 or 212-983-9330 (Ext. 1310). You may also click here for additional information: www.faruqilaw.com/INSP.
By Faruqi & Faruqi LLP · Via GlobeNewswire · February 15, 2024
ROSEN, A LEADING LAW FIRM, Encourages Inspire Medical Systems, Inc. Investors to Secure Counsel Before Important February 20 Deadline in Securities Class Action - INSP
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.
Via NewMediaWire · February 13, 2024
ROSEN, A LEADING LAW FIRM, Encourages Inspire Medical Systems, Inc. Investors to Secure Counsel Before Important February 20 Deadline in Securities Class Action - INSP
WHY: NEW YORK, NY - (NewMediaWire) - February 13, 2024 - Rosen Law Firm, a global investor rights law firm, reminds purchasers of common stock of Inspire Medical Systems, Inc. (NYSE: INSP) between May 3, 2023 and November 7, 2023, both dates inclusive (the “Class Period”), of the important February 20, 2024 lead plaintiff deadline.
Via TheNewswire.com · February 13, 2024
ROSEN, SKILLED INVESTOR COUNSEL, Encourages Inspire Medical Systems, Inc. Investors to Secure Counsel Before Important February 20 Deadline in Securities Class Action – INSP
NEW YORK, Feb. 13, 2024 (GLOBE NEWSWIRE) --
By The Rosen Law Firm PA · Via GlobeNewswire · February 13, 2024
INSPIRE MEDICAL SYSTEMS, INC. (NYSE: INSP) DEADLINE ALERT: Bernstein Liebhard LLP Reminds Investors of the Deadline to File a Lead Plaintiff Motion in a Securities Class Action Lawsuit Against Inspire Medical Systems, Inc.
NEW YORK, Feb. 13, 2024 (GLOBE NEWSWIRE) -- Bernstein Liebhard LLP:
By Bernstein Liebhard LLP · Via GlobeNewswire · February 13, 2024
Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Lovesac, Golden Heaven, Inspire Medical, and Driven and Encourages Investors to Contact the Firm
NEW YORK, Feb. 12, 2024 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, reminds investors that class actions have been commenced on behalf of stockholders of Lovesac Company (NASDAQ: LOVE), Golden Heaven Group Holdings Ltd. (NASDAQ: GDHG), Inspire Medical Systems, Inc. (NYSE: INSP), and Driven Brands Holdings, Inc. (NASDAQ: DRVN). Stockholders have until the deadlines below to petition the court to serve as lead plaintiff. Additional information about each case can be found at the link provided.
By Bragar Eagel & Squire · Via GlobeNewswire · February 12, 2024
ROSEN, TOP RANKED GLOBAL COUNSEL, Encourages Inspire Medical Systems, Inc. Investors with Losses to Secure Counsel Before Important February 20 Deadline in Securities Class Action - INSP
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.
Via NewMediaWire · February 11, 2024
ROSEN, TOP RANKED GLOBAL COUNSEL, Encourages Inspire Medical Systems, Inc. Investors with Losses to Secure Counsel Before Important February 20 Deadline in Securities Class Action - INSP
WHY: NEW YORK, NY - (NewMediaWire) - February 11, 2024 - Rosen Law Firm, a global investor rights law firm, reminds purchasers of common stock of Inspire Medical Systems, Inc. (NYSE: INSP) between May 3, 2023 and November 7, 2023, both dates inclusive (the “Class Period”), of the important February 20, 2024 lead plaintiff deadline.
Via TheNewswire.com · February 11, 2024
INSPIRE MEDICAL INVESTOR DEADLINE APPROACHING: Faruqi & Faruqi Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $100,000 In Inspire Medical To Contact Him Directly To Discuss Their Options
If you suffered losses exceeding $100,000 investing in Inspire Medical stock or options between May 3, 2023 and November 7, 2023 and would like to discuss your legal rights, call Faruqi & Faruqi partner Josh Wilson directly at 877-247-4292 or 212-983-9330 (Ext. 1310). You may also click here for additional information: www.faruqilaw.com/INSP.
By Faruqi & Faruqi LLP · Via GlobeNewswire · February 8, 2024
ROSEN, A LEADING AND TOP RANKED LAW FIRM, Encourages Inspire Medical Systems, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - INSP
WHY: NEW YORK, NY - (NewMediaWire) - February 06, 2024 - Rosen Law Firm, a global investor rights law firm, reminds purchasers of common stock of Inspire Medical Systems, Inc. (NYSE: INSP) between May 3, 2023 and November 7, 2023, both dates inclusive (the “Class Period”), of the important February 20, 2024 lead plaintiff deadline.
Via NewMediaWire · February 6, 2024
ROSEN, A LEADING AND TOP RANKED LAW FIRM, Encourages Inspire Medical Systems, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - INSP
WHY: NEW YORK, NY - (NewMediaWire) - February 06, 2024 - Rosen Law Firm, a global investor rights law firm, reminds purchasers of common stock of Inspire Medical Systems, Inc. (NYSE: INSP) between May 3, 2023 and November 7, 2023, both dates inclusive (the “Class Period”), of the important February 20, 2024 lead plaintiff deadline.
Via TheNewswire.com · February 6, 2024
INSPIRE MEDICAL SYSTEMS, INC. (NYSE: INSP) DEADLINE ALERT: Bernstein Liebhard LLP Reminds Investors of the Deadline to File a Lead Plaintiff Motion in a Securities Class Action Lawsuit Against Inspire Medical Systems, Inc.
NEW YORK, Feb. 06, 2024 (GLOBE NEWSWIRE) -- Bernstein Liebhard LLP:
By Bernstein Liebhard LLP · Via GlobeNewswire · February 6, 2024
ROSEN, A TRUSTED AND LEADING LAW FIRM, Encourages Inspire Medical Systems, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - INSP
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.
Via NewMediaWire · February 5, 2024
ROSEN, A TRUSTED AND LEADING LAW FIRM, Encourages Inspire Medical Systems, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - INSP
WHY: NEW YORK, NY - (NewMediaWire) - February 05, 2024 - Rosen Law Firm, a global investor rights law firm, reminds purchasers of common stock of Inspire Medical Systems, Inc. (NYSE: INSP) between May 3, 2023 and November 7, 2023, both dates inclusive (the “Class Period”), of the important February 20, 2024 lead plaintiff deadline.
Via TheNewswire.com · February 5, 2024
Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Eagle Pharmaceuticals, Golden Heaven, Inspire Medical, and Driven and Encourages Investors to Contact the Firm
NEW YORK, Feb. 04, 2024 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, reminds investors that class actions have been commenced on behalf of stockholders of Eagle Pharmaceuticals, Inc. (NASDAQ: EGRX), Golden Heaven Group Holdings Ltd. (NASDAQ: GDHG), Inspire Medical Systems, Inc. (NYSE: INSP), and Driven Brands Holdings, Inc. (NASDAQ: DRVN). Stockholders have until the deadlines below to petition the court to serve as lead plaintiff. Additional information about each case can be found at the link provided.
By Bragar Eagel & Squire · Via GlobeNewswire · February 4, 2024
ROSEN, A RANKED AND LEADING FIRM, Encourages Inspire Medical Systems, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – INSP
NEW YORK, Feb. 04, 2024 (GLOBE NEWSWIRE) --
By The Rosen Law Firm PA · Via GlobeNewswire · February 4, 2024
ROSEN, A TOP RANKED LAW FIRM, Encourages Inspire Medical Systems, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - INSP
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.
Via NewMediaWire · February 3, 2024
ROSEN, A TOP RANKED LAW FIRM, Encourages Inspire Medical Systems, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - INSP
WHY: NEW YORK, NY - (NewMediaWire) - February 03, 2024 - Rosen Law Firm, a global investor rights law firm, reminds purchasers of common stock of Inspire Medical Systems, Inc. (NYSE: INSP) between May 3, 2023 and November 7, 2023, both dates inclusive (the “Class Period”), of the important February 20, 2024 lead plaintiff deadline.
Via TheNewswire.com · February 3, 2024